Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

The treatment was ineffective in humans.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Tofacitinib may help treat hair loss in children with alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib might be used to treat hair loss.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Tofacitinib helped a woman regrow hair with no major side effects.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Mitf plays a key role in melanoma progression and is linked to disease stage.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

JAK inhibitors are effective treatments for alopecia areata.